Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jennifer Meinecke"'
Autor:
Sebastian Baehs, Christoph J. Auernhammer, Kathrin Zitzmann, Enrico N. De Toni, B. Göke, Heinrich H. D. Meyer, Jennifer Meinecke, Gerald Spöttl, Stephan Brand
Publikováno v:
Cancer research. 67(10)
IFN-α is commonly used for biotherapy of neuroendocrine carcinomas. However, its antitumor efficacy is often limited due to IFN resistance. In this study, we evaluate the role of suppressor of cytokine signaling protein 1 (SOCS1) in modulating the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33a55f3c7e94d470e59b07ecfad6e11e
https://pubmed.ncbi.nlm.nih.gov/17510435
https://pubmed.ncbi.nlm.nih.gov/17510435
Autor:
Stephan Brand, Heinrich H. D. Meyer, Enrico N. De Toni, Kathrin Zitzmann, Burkhard Göke, Christoph J. Auernhammer, Jennifer Meinecke, Gerald Spöttl
Background/Aim: Tumors exhibiting constitutively activated PI(3)K/Akt/mTOR signaling are hypersensitive to mTOR inhibitors such as RAD001 (everolimus) which is presently being investigated in clinical phase II trials in various tumor entities, includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::216c4f8f5e71265eb3120de9576c8eca
https://mediatum.ub.tum.de/1218937
https://mediatum.ub.tum.de/1218937
Autor:
Stephan Brand, Heinrich H. D. Meyer, Sebastian Baehs, Kathrin Zitzmann, Christoph J. Auernhammer, Burkhard Göke, Gerald Spöttl, Jennifer Meinecke
Publikováno v:
Biochemical and biophysical research communications. 344(4)
Interferon-alpha (IFN-alpha) is used for biotherapy of neuroendocrine carcinomas. The interferon-lambdas (IL-28A/B and IL-29) are a novel group of interferons. In this study, we investigated the effects of the IFN-lambdas IL-28A and IL-29 on human ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dbe48fe45faf524cbcab09dc3efffd4
https://pubmed.ncbi.nlm.nih.gov/16650825
https://pubmed.ncbi.nlm.nih.gov/16650825